Zhejiang Shengda Bio-Pharm Co., Ltd.

¥11.33As of Sun 8 Nov 2026, 12:00 UTC
SSE:603079Healthcare
Country China
PE (Fwd) •••
TSR 9Y CAGR (5.16%)
Div yield 0.88%
ROE 2.64%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.48
PE TTM 63.15
TSR TTM (36.85%)
Mkt cap ¥2.124B
ROIC 3.25%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥12
3.24%
(82.28%)
Hold 5|1|10|5|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.12
0.12
0.12
0.12
(7.89%)
(10.47%)
(8.92%)
(6.30%)
Revenue¥M
117.8
121.5
128.4
133.6
11.62%
14.96%
14.87%
15.10%
Peers (US$318.3M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.140
0.381
0.249
EBIT/Intx
1.186
0.214
0.286
Own earn%
(40.23)
17.51
17.86
Sh yield%
34.48
48.04
45.51
Owners
Insiders/Inst%
1.57
42.24
Short interest%
0.95
SBC / revenue%
5.55
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
1–5
$1 testx
0.0
Incr. ROIC%
−1